Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19)
dong chen Jr., Xiaokuni Li, qifa song Sr., Chenchan Hu Jr., Feifei Su, Jianyi Dai
doi: https://doi.org/10.1101/2020.02.27.20028530
Abstract
BACKGROUND: SARS-CoV-2 has caused a series of COVID-19 globally. SARS-CoV-2 binds angiotensin I converting enzyme 2 (ACE2) of renin-angiotensin system (RAS) and causes prevalent hypokalemia METHODS: The patients with COVID-19 were classified into severe hypokalemia, hypokalemia, and normokalemia group. The study aimed to determine the relationship between hypokalemia and clinical features, the underlying causes and clinical implications of hypokalemia.
*注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.